Mode
Text Size
Log in / Sign up
N/A N=238 Randomized Treatment

Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery

Obesity, Severe · Cesarean Section

Enrolled (actual)
238
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Composite Wound Complication at Hospital Discharge and 2 Weeks Postpartum — 8; 5; 15; 16 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Absorbable subcuticular suture (Device); Stainless steel staples (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
MemorialCare Health System
Primary completion
Oct 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Composite Wound Complication at Hospital Discharge and 2 Weeks Postpartum
8; 5; 15; 16; 23; 21
SECONDARY
Number of Participants According to Skin Incision
114; 118; 5; 1
SECONDARY
Operating Surgeon Level
67; 66; 52; 53
SECONDARY
Surgical Assistant Level
101; 97; 18; 22
SECONDARY
Total Operative Time
43.4; 55.8
SECONDARY
Total Blood Loss
773; 837
SECONDARY
Number of Participants With Blood Transfusion
4; 8
SECONDARY
Change in Hemoglobin (Pre-delivery and Post-delivery)
1.68; 1.93
SECONDARY
Neonatal Birthweight
3406; 3426
SECONDARY
Number of Participants With 5 Minute Apgar Score <7
2; 1
SECONDARY
Number of Participants Receiving Postpartum Prophylactic Anticoagulation
66; 74
SECONDARY
Total Length of Hospital Stay
4.9; 4.9
SECONDARY
Patient Pain Score (From 1 to 10)
2; 2
SECONDARY
Patient Satisfaction With Wound Healing and Appearance
10; 10; 1; 1

Summary

The purpose of this study is to determine the optimal skin closure technique (staples versus subcuticular suture) at the time of cesarean delivery in Class III obese women with body mass index (BMI) of >/= 40kg/m2.

Eligibility Criteria

Inclusion Criteria

  • Women > 18 years old undergoing cesarean delivery (CD)
  • BMI of >/= 40 kg/m2 as determined by height and weight reported during their admission
  • Live gestation 23 weeks or greater
  • Women who are able to follow-up 7-14 days after hospital discharge for a visual wound check.

Exclusion Criteria

  • Active lupus flare
  • HIV/AIDS
  • Current treatment for cancer or h/o radiation to the abdomen/pelvis
  • Hypersensitivity to steri-strips
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02466776). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search